Results 181 to 190 of about 100,511 (312)

O2‐Mediated Cu‐Catalyzed Dehydrogenative Sulfilimination of Tyrosines and Bioactive Phenols

Advanced Synthesis &Catalysis, Volume 368, Issue 9, 5 May 2026.
We report herein the mild O2‐mediated Cu‐catalyzed dehydrogenative sulfilimination of diverse bioactive phenols with simple sulfenamides. The bioconjugation of unmodified native peptides, in particular at their tyrosine units with the dehydrogenative phenochalcogenazination reaction, has attracted much attention lately due to potential click type ...
Fang Xiao, Frederic W. Patureau
wiley   +1 more source

Clinical Evaluation of Neonatal Arrhythmias: Experience from a Specialized Pediatric Cardiac Center. [PDF]

J Cardiovasc Dev Dis
Genc HZ, Karimov E, Yakut S, Yavuzcan Ozturk D, Oguz D, Cetinkaya M, Tunca Sahin G, Ozturk E.   +7 more
europepmc   +1 more source

Understanding CPVT pathogenic mechanisms based on mutation location within RyR2: towards personalized medicine?

The Journal of Physiology, EarlyView.
Jean‐Pierre Benitah, Esther Zorio, Ana María Gómez   +2 more
wiley   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1287-1308, May 2026.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

Antiarrhythmic drugs for cardiac arrest with a shockable rhythm and their effect on outcomes: a systematic review with meta-analysis. [PDF]

Europace
Schnaubelt S, Veigl C, Kornfehl A, Brock R, Tapinova K, Krammel M, Wildner B, Sossalla S, Niessner A, Sulzgruber P.   +9 more
europepmc   +1 more source

Successful Management of Fetal Supraventricular Tachycardia With Flecainide in a Case Complicated by Early Hydrops Fetalis: A Case Report

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Fetal arrhythmia that can lead to hydrops fetalis and fetal heart failure if untreated. This case report describes the successful treatment of a fetus with SVT at 26 weeks of gestation using flecainide. A 37‐year‐old gravida 3, para 2 woman was diagnosed with fetal SVT during a routine ultrasound, which also revealed mild pleural effusion ...
Amirabbas Faridpour, Yazdan Ghandi, Alireza Golbabaei   +2 more
wiley   +1 more source

ECG-Guided Antiarrhythmic Therapy in Acute Coronary Syndrome: A Multidimensional Assessment of Biomarkers, Cardiac Function, and Quality of Life. [PDF]

Ther Clin Risk Manag
Li X, Liu X, Jing M, Yang C, Luo H, Li L.   +5 more
europepmc   +1 more source

Progressive myocardial metabolic dysfunction after stereotactic arrhythmia radioablation for ventricular tachycardia in hypertrophic cardiomyopathy: a serial multimodality imaging case report. [PDF]

Eur Heart J Case Rep
Shimojo M, Kawamura M, Inden Y, Naganawa S, Murohara T.   +4 more
europepmc   +1 more source

Hopes and disappointments with antiarrhythmic drugs.

International Journal of Cardiology, 2017
A. Camm
semanticscholar   +1 more source

Daily Remote Monitoring of Pediatric Patients With Cardiac Implantable Electronic Devices: Early Arrhythmia Detection and Timely Clinical Intervention

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT In recent years, significant progress has been made in the management of pediatric arrhythmias through the use of cardiac implantable electronic devices (CIEDs) such as pacemakers (PMs) and implantable cardioverter‐defibrillators (ICDs).
Piotr Wieniawski, Jakub Zabłocki, Bożena Werner   +2 more
wiley   +1 more source